Educational research profile

CJC-1295

CJC-1295 is a growth-hormone-releasing hormone analogue studied in early research. Products marketed under the same name may vary in composition and duration of action.

Growth Hormone ResearchEarly Human / PreclinicalStudy-dependent

Educational content only. This page does not diagnose, prescribe, recommend a supplier, or provide individualized dosing instructions.

Research Context

CJC-1295 is a growth-hormone-releasing hormone analogue studied in early research. Products marketed under the same name may vary in composition and duration of action.

Research topics mentioned

Growth-hormone axis research
Pharmacokinetic research

Safety & Evidence Limits

Potential concerns include injection reactions, flushing, headache, hormone-related effects, contamination, and unknown long-term risk.

Protocol note

No dosing guidance is provided. Experimental protocols require professional oversight and verified products.

Related Research Terms

Ipamorelin

A pairing listed here reflects common research discussion, not a recommendation.

Sources & Review Standard

Peer-reviewed early clinical and pharmacology literature

Last updated 7/7/2026.

CJC-1295 FAQ

Why do CJC-1295 products differ?

Names may be used for different formulations. Documentation and independent testing are important.

Related Educational Profiles

Explore profiles in the same broad research category.

All Categories

Ipamorelin

Growth Hormone ResearchEarly Human / Preclinical

Ipamorelin is a growth-hormone secretagogue studied for its activity at the ghrelin receptor. Evidence and regulatory status remain limited for many uses promoted online.

Read Profile

Tesamorelin

Growth Hormone ResearchApproved Clinical Context

Tesamorelin is a growth-hormone-releasing factor analogue with a specific approved clinical indication in some jurisdictions. That approval does not extend to all online marketing claims.

Read Profile